| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2001; 40: 1398-1404
© 2001 British Society for Rheumatology
Original Papers |
Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease
Section of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan
Objective. To determine cytokines and MHC class II alleles in Japanese patients with adult Still's disease (ASD) and clarify the association between those profiles and chronic articular disease.
Methods. Of 35 patients with ASD (13 men, 22 women, mean age at onset 34.0 yr), 17 (49%) had chronic arthritis (>6 months, chronic articular ASD) and 18 (51%) lacked chronic arthritis (systemic ASD). Cytokines and cytokine receptors in sera were measured by ELISA. Correlations of each cytokine with disease activity or C-reactive protein (CRP) were determined. MHC class II alleles were examined by polymerase chain reaction methods.
Results. In chronic articular ASD, female gender was more frequent and liver dysfunction and myalgia were rarer than in systemic ASD. In active disease, the white blood cell count was lower, but total IgG was greater in patients with chronic articular ASD than in those with systemic ASD. Tumour necrosis factor (TNF)
, soluble TNF receptor 2 and interleukin (IL)-18 were increased in both types of ASD, even in remission. Soluble IL-2 receptors, IL-4 and IL-18 levels were correlated with disease activity or CRP value only in chronic articular ASD. Interferon
and IL-8 remained increased only in chronic articular ASD, even when disease activity, including IL-6 and CRP, was low. DRB1*1501 (DR2) and DRB1*1201 (DR5) alleles were more frequent in chronic articular than in systemic ASD, whereas DQB1*0602 (DQ1) was frequently observed in both types of ASD.
Conclusion. The present study suggests that ASD with chronic articular disease has distinct clinical, cytokine and immunogenetic profiles.
KEY WORDS: Adult Still's disease, Cytokines, MHC class II alleles, Chronic arthritis.
Correspondence to: T. Fujii, Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D.-Y. CHEN, Y.-M. CHEN, H.-H. CHEN, C.-W. HSIEH, C.-C. LIN, and J.-L. LAN Functional Association of Interleukin 18 Gene -607 (C/A) Promoter Polymorphisms with Disease Course in Chinese Patients with Adult-onset Still's Disease J Rheumatol, October 1, 2009; 36(10): 2284 - 2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-T. LEE, W.-S. CHEN, K.-H. SUN, C.-T. CHOU, and C.-Y. TSAI Increased Spontaneous But Decreased Mitogen-stimulated Expression and Excretion of Interleukin 18 by Mononuclear Cells in Patients with Active Systemic Lupus Erythematosus J Rheumatol, September 1, 2009; 36(9): 1910 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Woo Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease Ann Rheum Dis, March 1, 2008; 67(3): 281 - 282. [Full Text] [PDF] |
||||
![]() |
T Lequerre, P Quartier, D Rosellini, F Alaoui, M De Bandt, O Mejjad, I Kone-Paut, M Michel, E Dernis, M Khellaf, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France Ann Rheum Dis, March 1, 2008; 67(3): 302 - 308. [Abstract] [Full Text] [PDF] |
||||

